USD 42.46
(-1.32%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.61 Billion USD | -7.46% |
2022 | 2.82 Billion USD | 1938.1% |
2021 | 138.59 Million USD | 27.73% |
2020 | 108.5 Million USD | -3.38% |
2019 | 112.3 Million USD | 4.4% |
2018 | 107.56 Million USD | -72.94% |
2017 | 397.44 Million USD | 167.79% |
2016 | 148.41 Million USD | 0.34% |
2015 | 147.91 Million USD | 0.47% |
2014 | 147.22 Million USD | 2544.57% |
2013 | 5.56 Million USD | -49.15% |
2012 | 10.94 Million USD | -77.17% |
2011 | 47.94 Million USD | -39.9% |
2010 | 79.77 Million USD | 655.72% |
2009 | 10.55 Million USD | 50.82% |
2008 | 6.99 Million USD | -9.85% |
2007 | 7.76 Million USD | -8.0% |
2006 | 8.43 Million USD | -42.63% |
2005 | 14.71 Million USD | 52.01% |
2004 | 9.67 Million USD | -5.09% |
2003 | 10.19 Million USD | -4.26% |
2002 | 10.65 Million USD | -22.42% |
2001 | 13.72 Million USD | -4.65% |
2000 | 14.39 Million USD | 0.0% |
1998 | 3 Million USD | -6.25% |
1997 | 3.2 Million USD | -5.88% |
1996 | 3.4 Million USD | -26.09% |
1995 | 4.6 Million USD | -9.8% |
1994 | 5.1 Million USD | -26.09% |
1993 | 6.9 Million USD | -1.43% |
1992 | 7 Million USD | 1.45% |
1991 | 6.9 Million USD | -12.66% |
1990 | 7.9 Million USD | 259.09% |
1989 | 2.2 Million USD | -35.29% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 2.77 Billion USD | 6.05% |
2024 Q1 | 2.61 Billion USD | -0.05% |
2023 Q4 | 2.61 Billion USD | -1.11% |
2023 Q2 | 2.69 Billion USD | -2.65% |
2023 Q1 | 2.77 Billion USD | -1.92% |
2023 FY | 2.61 Billion USD | -7.46% |
2023 Q3 | 2.64 Billion USD | -1.99% |
2022 Q4 | 2.82 Billion USD | -0.96% |
2022 FY | 2.82 Billion USD | 1938.1% |
2022 Q2 | 2.9 Billion USD | 1901.13% |
2022 Q1 | 145.38 Million USD | 4.9% |
2022 Q3 | 2.85 Billion USD | -1.97% |
2021 FY | 138.59 Million USD | 27.73% |
2021 Q4 | 138.59 Million USD | -2.97% |
2021 Q1 | 146.19 Million USD | 34.73% |
2021 Q2 | 4.32 Million USD | -97.04% |
2021 Q3 | 142.83 Million USD | 3206.25% |
2020 Q2 | 136.66 Million USD | 23.26% |
2020 Q4 | 108.5 Million USD | -6.86% |
2020 FY | 108.5 Million USD | -3.38% |
2020 Q1 | 110.87 Million USD | -1.27% |
2020 Q3 | 116.49 Million USD | -14.76% |
2019 Q3 | 107.25 Million USD | -9.47% |
2019 FY | 112.3 Million USD | 4.4% |
2019 Q2 | 118.47 Million USD | -33.17% |
2019 Q1 | 177.27 Million USD | 64.8% |
2019 Q4 | 112.3 Million USD | 4.7% |
2018 FY | 107.56 Million USD | -72.94% |
2018 Q1 | 226.87 Million USD | -42.92% |
2018 Q2 | 134.38 Million USD | -40.77% |
2018 Q3 | 137.07 Million USD | 2.0% |
2018 Q4 | 107.56 Million USD | -21.53% |
2017 FY | 397.44 Million USD | 167.79% |
2017 Q4 | 397.44 Million USD | 160.66% |
2017 Q1 | 149.76 Million USD | 0.91% |
2017 Q2 | 151.11 Million USD | 0.9% |
2017 Q3 | 152.47 Million USD | 0.9% |
2016 Q1 | 144.78 Million USD | -2.11% |
2016 FY | 148.41 Million USD | 0.34% |
2016 Q4 | 148.41 Million USD | 0.85% |
2016 Q3 | 147.17 Million USD | 0.82% |
2016 Q2 | 145.97 Million USD | 0.82% |
2015 FY | 147.91 Million USD | 0.47% |
2015 Q4 | 147.91 Million USD | 0.83% |
2015 Q2 | 145.48 Million USD | 0.83% |
2015 Q1 | 144.28 Million USD | -2.0% |
2015 Q3 | 146.69 Million USD | 0.83% |
2014 Q1 | 5.46 Million USD | -1.89% |
2014 Q2 | 5.35 Million USD | -1.98% |
2014 FY | 147.22 Million USD | 2544.57% |
2014 Q3 | 5.24 Million USD | -2.11% |
2014 Q4 | 147.22 Million USD | 2709.06% |
2013 Q1 | 5.85 Million USD | -46.51% |
2013 FY | 5.56 Million USD | -49.15% |
2013 Q4 | 5.56 Million USD | -1.76% |
2013 Q3 | 5.66 Million USD | -1.67% |
2013 Q2 | 5.76 Million USD | -1.59% |
2012 FY | 10.94 Million USD | -77.17% |
2012 Q4 | 10.94 Million USD | -42.38% |
2012 Q1 | 25.19 Million USD | -47.8% |
2012 Q2 | 25.11 Million USD | -0.33% |
2012 Q3 | 19 Million USD | -24.35% |
2011 Q1 | 49.93 Million USD | -37.63% |
2011 Q4 | 48.27 Million USD | -2.22% |
2011 FY | 47.94 Million USD | -39.9% |
2011 Q3 | 49.37 Million USD | -1.31% |
2011 Q2 | 50.02 Million USD | 0.18% |
2010 Q3 | 80.18 Million USD | -3.75% |
2010 Q4 | 80.05 Million USD | -0.17% |
2010 FY | 79.77 Million USD | 655.72% |
2010 Q1 | 83.57 Million USD | 1136.13% |
2010 Q2 | 83.31 Million USD | -0.31% |
2009 FY | 10.55 Million USD | 50.82% |
2009 Q1 | 6.79 Million USD | -2.97% |
2009 Q2 | 6.57 Million USD | -3.14% |
2009 Q3 | 6.35 Million USD | -3.33% |
2009 Q4 | 6.76 Million USD | 6.32% |
2008 Q4 | 6.99 Million USD | -2.74% |
2008 FY | 6.99 Million USD | -9.85% |
2008 Q2 | 7.39 Million USD | -2.49% |
2008 Q3 | 7.19 Million USD | -2.63% |
2008 Q1 | 7.57 Million USD | -2.38% |
2007 Q2 | 8.1 Million USD | -2.02% |
2007 FY | 7.76 Million USD | -8.0% |
2007 Q4 | 7.76 Million USD | -2.19% |
2007 Q3 | 7.93 Million USD | -2.11% |
2007 Q1 | 8.27 Million USD | -1.93% |
2006 FY | 8.43 Million USD | -42.63% |
2006 Q1 | 8.92 Million USD | -39.32% |
2006 Q3 | 8.59 Million USD | -1.94% |
2006 Q4 | 8.43 Million USD | -1.78% |
2006 Q2 | 8.76 Million USD | -1.84% |
2005 Q1 | 9.53 Million USD | -1.48% |
2005 FY | 14.71 Million USD | 52.01% |
2005 Q4 | 14.71 Million USD | 59.22% |
2005 Q3 | 9.23 Million USD | -1.6% |
2005 Q2 | 9.38 Million USD | -1.52% |
2004 Q4 | 9.67 Million USD | -1.37% |
2004 Q3 | 9.81 Million USD | -1.32% |
2004 Q2 | 9.94 Million USD | -1.27% |
2004 Q1 | 10.07 Million USD | -1.24% |
2004 FY | 9.67 Million USD | -5.09% |
2003 Q3 | 10.31 Million USD | -1.1% |
2003 Q4 | 10.19 Million USD | -1.13% |
2003 FY | 10.19 Million USD | -4.26% |
2003 Q1 | 10.54 Million USD | -1.02% |
2003 Q2 | 10.42 Million USD | -1.07% |
2002 FY | 10.65 Million USD | -22.42% |
2002 Q4 | 10.65 Million USD | -0.96% |
2002 Q3 | 10.75 Million USD | -0.92% |
2002 Q2 | 10.85 Million USD | -0.89% |
2002 Q1 | 10.95 Million USD | -20.24% |
2001 Q4 | 13.72 Million USD | 3.73% |
2001 FY | 13.72 Million USD | -4.65% |
2001 Q2 | 14.75 Million USD | -2.03% |
2001 Q3 | 13.23 Million USD | -10.31% |
2001 Q1 | 15.06 Million USD | 4.6% |
2000 FY | 14.39 Million USD | 0.0% |
2000 Q1 | 14.66 Million USD | 0.0% |
2000 Q4 | 14.39 Million USD | 24.14% |
2000 Q2 | 13.2 Million USD | -10.0% |
2000 Q3 | 11.59 Million USD | -12.14% |
1999 Q3 | 11.2 Million USD | 273.33% |
1999 Q2 | 3 Million USD | 0.0% |
1999 Q1 | 3 Million USD | -3.23% |
1998 Q3 | 3.1 Million USD | -3.13% |
1998 Q4 | 3.1 Million USD | 0.0% |
1998 FY | 3 Million USD | -6.25% |
1998 Q1 | 3.2 Million USD | -3.03% |
1998 Q2 | 3.2 Million USD | 0.0% |
1997 Q1 | 3.4 Million USD | -5.56% |
1997 Q2 | 3.4 Million USD | 0.0% |
1997 FY | 3.2 Million USD | -5.88% |
1997 Q4 | 3.3 Million USD | 0.0% |
1997 Q3 | 3.3 Million USD | -2.94% |
1996 Q1 | 4.6 Million USD | -6.12% |
1996 FY | 3.4 Million USD | -26.09% |
1996 Q2 | 4.1 Million USD | -10.87% |
1996 Q3 | 3.9 Million USD | -4.88% |
1996 Q4 | 3.6 Million USD | -7.69% |
1995 Q4 | 4.9 Million USD | 13.95% |
1995 Q2 | 5.1 Million USD | 0.0% |
1995 Q3 | 4.3 Million USD | -15.69% |
1995 FY | 4.6 Million USD | -9.8% |
1995 Q1 | 5.1 Million USD | -22.73% |
1994 Q2 | 6.7 Million USD | -2.9% |
1994 Q4 | 6.6 Million USD | 11.86% |
1994 Q1 | 6.9 Million USD | 0.0% |
1994 Q3 | 5.9 Million USD | -11.94% |
1994 FY | 5.1 Million USD | -26.09% |
1993 Q3 | - USD | -100.0% |
1993 Q2 | 7.1 Million USD | 1.43% |
1993 Q1 | 7 Million USD | 0.0% |
1993 FY | 6.9 Million USD | -1.43% |
1993 Q4 | - USD | 0.0% |
1992 Q3 | 6.9 Million USD | -1.43% |
1992 FY | 7 Million USD | 1.45% |
1992 Q1 | 6.9 Million USD | -1.43% |
1992 Q2 | 7 Million USD | 1.45% |
1992 Q4 | 7 Million USD | 1.45% |
1991 Q1 | 7.9 Million USD | 0.0% |
1991 Q3 | 7.1 Million USD | -6.58% |
1991 Q2 | 7.6 Million USD | -3.8% |
1991 Q4 | 7 Million USD | -1.41% |
1991 FY | 6.9 Million USD | -12.66% |
1990 Q1 | 2.2 Million USD | 0.0% |
1990 FY | 7.9 Million USD | 259.09% |
1989 FY | 2.2 Million USD | -35.29% |
1989 Q1 | 3.4 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -2950.078% |
AngioDynamics, Inc. | 5.91 Million USD | -44101.894% |
AtriCure, Inc. | 74.49 Million USD | -3409.142% |
Avinger, Inc. | 15.39 Million USD | -16880.188% |
Azenta, Inc. | 60.43 Million USD | -4225.402% |
BioLife Solutions, Inc. | 42.69 Million USD | -6023.305% |
The Cooper Companies, Inc. | 2.56 Billion USD | -1.748% |
Daxor Corporation | 755.65 Thousand USD | -345836.461% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -36369.029% |
Femasys Inc. | 6.7 Million USD | -38911.282% |
GlucoTrack, Inc. | 196 Thousand USD | -1333624.49% |
Harvard Bioscience, Inc. | 42.77 Million USD | -6011.566% |
Hologic, Inc. | 2.53 Billion USD | -3.137% |
ICU Medical, Inc. | 1.7 Billion USD | -53.345% |
Intuitive Surgical, Inc. | 89.8 Million USD | -2811.024% |
KORU Medical Systems, Inc. | 4.44 Million USD | -58708.311% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -13589.971% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | -169.495% |
Microbot Medical Inc. | 231 Thousand USD | -1131545.022% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -35557.512% |
Merit Medical Systems, Inc. | 891.35 Million USD | -193.271% |
Nephros, Inc. | 1.83 Million USD | -142280.174% |
NovoCure Limited | 596.24 Million USD | -338.429% |
NEXGEL, Inc. | 2.79 Million USD | -93327.448% |
NEXGEL, Inc. | 2.79 Million USD | -93327.448% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -3372.134% |
OraSure Technologies, Inc. | 13.5 Million USD | -19257.968% |
Pro-Dex, Inc. | 13.54 Million USD | -19196.523% |
Pulse Biosciences, Inc. | 9.14 Million USD | -28488.145% |
Predictive Oncology Inc. | 2.85 Million USD | -91404.032% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -76013.836% |
Repligen Corporation | 711.8 Million USD | -267.25% |
Sanara MedTech Inc. | 11.79 Million USD | -22068.212% |
STAAR Surgical Company | 35.83 Million USD | -7195.027% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -764256.725% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | -13.706% |
Jin Medical International Ltd. | 4.11 Million USD | -63457.014% |